MedPath

Utilization of the Mirror During Pelvic Exams

Completed
Conditions
Pelvic Exam
Interventions
Other: Usage of a mirror
Registration Number
NCT03785548
Lead Sponsor
TriHealth Inc.
Brief Summary

This is a prospective cohort study to determine if using a birthing mirror during the patient's pelvic examination decreases patients's degree of vulnerability and discomfort.

Detailed Description

In Obstetrics and Gynecology and its gynecologic subspecialties, the pelvic examination is routine practice for screening and diagnostic purposes. Nevertheless, due to their intimate nature, pelvic examinations may result in loss of control, embarrassment, discomfort and anxiety.

The mirror pelvic exam has been a proposed technique to decrease patient anxiety and improve comfort during an already uncomfortable examination. However, little research has focused on this modality to date.

The purpose of this study is to investigate whether the mirror pelvic exam decreases the level of vulnerability and discomfort experienced during the pelvic examination.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
147
Inclusion Criteria
  • New patients undergoing a pelvic exam performed by a physician at Cincinnati Urogynecology Associates, TriHealth
Exclusion Criteria
  • Existing patients
  • Unwillingness to participate in the study
  • Physical or mental impairment that would affect the subject's ability to visualize the mirror during examination or to complete questionnaires
  • Inability to understand English

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Mirror groupUsage of a mirrorThis group of patients agree to have the mirror pelvic exam, and they will undergo routine pelvic examination by a physician with the usage of a mirror in the room.
Primary Outcome Measures
NameTimeMethod
Group Difference in Visual Analog Scale (VAS) on Level of Vulnerability30 minutes after the pelvic exam

VAS on vulnerability level will be measured after the pelvic exam, and group difference after controlling for baseline vulnerability, will be calculated. The VAS is a validated 100 millimeter scale with 'no vulnerability' represented as 0 mm and 'very vulnerable' equating to 100 mm.

Group Difference in Visual Analog Scale (VAS) on Level of Pain/Discomfort30 minutes after the pelvic exam

VAS on discomfort level will be measured after the pelvic exam, and group difference after controlling for baseline discomfort level, will be calculated. The VAS is a validated 100 millimeter scale with 'no pain' represented as 0 mm and 'most pain' equating to 100 mm.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cincinnati Urogynecology Associates

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath